Dr. Schmidt partner in consortium that receives H2020 Marie-Curie EJD grant
Dr. Sandy Schmidt , a new Assistant Professor and Rosalind Franklin Fellow in the Groningen Research Institute of Pharmacy ( GRIP ), is partner in a consortium that has been awarded a H2020 Marie Curie EJD grant. The grant of EUR 2.9 million is for the ConCO2rde project: a training network on the conversion of CO2 by smart autotrophic biorefineries. The aim is to develop processes for the utilization of renewable resources by CO2-fixing microorganisms.
The CONCO2RDE EJD will train 11 Early Stage Researchers (ESR) in cutting edge research projects on
- the combination of synthetic biology approaches with metabolic and process engineering to create an efficient route from CO2 fixation to the production of chemicals;
- H2/CO2/O2-based fermentation and process intensification in order to optimize commercially relevant processes together with industry;
- defining a road map for the industrial implementation of autotrophic biotransformations.
The double degree programme allows in-depth training in two complementary disciplines, further strengthened by a transferable skills training with strong industry participation. The ConCO2rde consortium consists of one translational institute, six universities, nine industrial partners and one cluster, providing the ideal environment to foster complementary expertise in synthetic biology, metabolic engineering, biocatalysis, process engineering and analytics. The acib GmbH (Graz, Austria) is the coordinating institution, whereby Dr. Schmidt acts as coordinating person on behalf of acib GmbH. Dr. Schmidt receives EUR 531,000 for her part of the project. She will provide expertise in synthetic biology and biocatalysis, with a focus on strain engineering and oxygenase-catalyzed biotransformations.

Last modified: | 19 October 2020 1.20 p.m. |
More news
-
25 April 2025
Leading microbiologist Arnold Driessen honoured
On 25 April 2025, Arnold Driessen (Horst, the Netherlands, 1958) received a Royal Decoration. Driessen is Professor of Molecular Microbiology and chair of the Molecular Microbiology research department of the Faculty of Science and Engineering at the...
-
24 April 2025
Highlighted papers April 2025
The antimalarial drug mefloquine could help treat genetic diseases such as cystic fibrosis, Duchenne muscular dystrophy, as well as some cancers.
-
22 April 2025
Microplastics and their effects on the human body
Professor of Respiratory Immunology Barbro Melgert has discovered how microplastics affect the lungs and can explain how to reduce our exposure.